Adherium Ltd. ( (AU:ADR) ) just unveiled an announcement.
Adherium Limited reported a 33% increase in operating revenue to $500,328 for the six months ending December 31, 2024, compared to the same period in 2023. Despite the revenue growth, the company experienced a 24% increase in net loss, amounting to $5,777,494, highlighting ongoing financial challenges. The report indicates no dividends were declared, and the net tangible assets per share decreased significantly from $0.014 to $0.002, reflecting the company’s current financial position.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on digital health technologies. The company primarily provides solutions for monitoring and managing respiratory conditions, aiming to improve patient outcomes and reduce healthcare costs.
YTD Price Performance: 30.0%
Average Trading Volume: 509,973
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$9.86M
See more data about ADR stock on TipRanks’ Stock Analysis page.